Daiichi Sankyo, Inc. to Enter Japan’s Generic Drug Market

Reuters -- Daiichi Sankyo (4568.T) said on Friday that it would enter Japan's generic-drug market this year, targeting fast-growing demand as the government promotes greater use of generics to offset rising healthcare costs.